Starting July 1, the Bridge program will serve as the Centers for Medicare & Medicaid Services (CMS) vehicle to provide expanded access to GLP-1 obesity medications.
This rename is a meaningful step toward better diagnosis and care, and long-overdue recognition of all that this condition encompasses.
My advice to other women is simple: trust your body, ask questions, seek second opinions & never minimize your own discomfort.
I was diagnosed with stage 4 endometriosis, a severe form of the disease that had spread beyond the reproductive organs and affected other parts of my body.
SWHR presented a session titled “Advancing Sex Differences Science in a Changing Advocacy Environment,” at the OSSD Annual Meeting in Kona, Hawaii.
Women should not have to struggle to be heard or fight to receive accurate care. Greater awareness, research, and understanding of conditions like PMDD are essential to improving outcomes for those affected.
The Society for Women’s Health Research (SWHR) and Women’s Health Research at Yale are co-hosting the collaborative symposium: “From Discovery to Impact: Accelerating Women's Health Research Through Science, Policy, and Investment."
SWHR remains committed to advocating for women living with rare diseases and ensuring they can live healthy lives.
The Menopause at Work study pairs a large-scale, multi-stakeholder survey with a series of in-person regional roundtables, each built to reach beyond the voices already discussing menopause and into the rooms where workplace decisions are actually made.